| Microinvasive Glaucoma Surgery -The Lowering Effect of Intraocular Pressure on Glaucoma Patients With High Frequency Deep Sclerotomy (NCT05466526) | National Taiwan University Hospital Hsin-Chu Branch | 2022-07-01 |
| Retinal Vascular Changes in Primary Open Angle Glaucoma Patients (NCT05351307) | Sohag University | 2022-06-01 |
| Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma (NCT05264818) | Fondation Ophtalmologique Adolphe de Rothschild | 2022-05-06 |
| Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial (NCT05844384) | 59th Medical Wing | 2022-03-17 |
| GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (NCT05253534) | Glaucot Teknoloji Anonim Sirketi | 2022-03-01 |
| Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma (NCT05247762) | China Medical University Hospital | 2022-02-28 |
| Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl (NCT05279716) | Santen Pharmaceutical Asia Pte. Ltd. | 2022-02-15 |
| Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution (NCT05315206) | Fondazione G.B. Bietti, IRCCS | 2022-01-25 |
| Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma (NCT06978101) | Assiut University | 2021-12-30 |
| A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT05022004) | Sun Pharmaceutical Industries Limited | 2021-12-20 |
| Safety and Effectiveness of the Hydrus Microstent (NCT05198297) | Alcon Research | 2021-12-13 |
| A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04863365) | pH Pharma | 2021-11-01 |
| Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting (NCT04828057) | Santen Pharmaceutical (Taiwan) Co., LTD | 2021-09-01 |
| Development and Validation of a Model to Predict Fast Progression in Glaucoma (NCT04454190) | Duke University | 2021-07-20 |
| Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty (NCT04769453) | Nova Eye, Inc. | 2021-04-29 |
| Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). (NCT04830397) | Qlaris Bio, Inc. | 2021-03-31 |
| Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD (NCT04891588) | Klinički Bolnički Centar Zagreb | 2021-03-08 |
| Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin (NCT04784234) | Wills Eye | 2021-02-01 |
| Study of LL-BMT1 in Patients With Elevated Intraocular Pressure (NCT04747808) | MediPrint Ophthalmics, Inc. | 2021-01-08 |
| Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent (NCT04629521) | Alcon Research | 2020-12-21 |
| Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04742283) | Santen Inc. | 2020-12-17 |
| Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT04620135) | Aerie Pharmaceuticals | 2020-11-30 |
| Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device (NCT04595227) | Peking University | 2020-10-30 |
| Malay Glaucoma Eye Study II Navigation, Mobility and Reading Ability in Primary Glaucoma (NCT04736264) | Universiti Sains Malaysia | 2020-10-01 |
| Hydrus® Microstent New Enrollment Post-Approval Study (NCT04553523) | Alcon Research | 2020-08-25 |
| Cyclophotocoagulation in Primary Open Angle Glaucoma (NCT04430296) | Cairo University | 2020-08-01 |
| Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy (NCT04440527) | Medical University Innsbruck | 2020-07-22 |
| Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT) (NCT04519814) | Carl Zeiss Meditec AG | 2020-06-30 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT04448223) | Chong Kun Dang Pharmaceutical | 2020-06-11 |
| PRESERFLO® MicroShunt Extension Study (NCT04333433) | InnFocus Inc. | 2020-05-22 |
| SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy. (NCT03931564) | Maastricht University Medical Center | 2020-02-01 |
| IOP and Medication Reduction in MIGS Procedures (NCT04202510) | Wills Eye | 2020-01-06 |
| Effect of Metformin on Visual Function in Patients With Glaucoma (NCT04155164) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2019-12-10 |
| Effect of Xen Implantation on the Aqueous Humor Proteome (NCT04141865) | Price Vision Group | 2019-10-24 |
| Decorin in Sub Scleral Trabeculectomy (NCT03924544) | Cairo University | 2019-09-01 |
| Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients (NCT04461249) | Kasr El Aini Hospital | 2019-06-01 |
| Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults (NCT04396002) | University of Alabama at Birmingham | 2019-06-01 |
| Tafluprost Preservative Free Switch Study (NCT04654611) | Tun Hussein Onn National Eye Hospital | 2019-02-01 |
| Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension (NCT02617459) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2019-01-04 |
| Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma (NCT04098861) | Universiti Kebangsaan Malaysia Medical Centre | 2019-01-02 |
| A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 (NCT03762369) | Chong Kun Dang Pharmaceutical | 2018-12-07 |
| Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study (NCT03921931) | Medical University of Vienna | 2018-11-26 |
| Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction (NCT03889652) | Kasr El Aini Hospital | 2018-10-20 |
| Impact of Glaucoma and Visual Field Loss on Life Space (NCT03673644) | University of Alabama at Birmingham | 2018-10-09 |
| Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG) (NCT03651336) | Implandata Ophthalmic Products GmbH | 2018-08-15 |
| Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma (NCT03480711) | Rehab mahmoud abdelhamid mohamed | 2018-07-10 |
| PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) (NCT03193333) | Laboratorios Sophia S.A de C.V. | 2017-11-06 |
| Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment (NCT03365778) | Wills Eye | 2017-10-23 |
| Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study (NCT03323164) | Wills Eye | 2017-07-10 |
| Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma (NCT02891317) | University of North Carolina, Chapel Hill | 2017-05-08 |
| PAIR Study-PAP And IOP Relationship: Study 2 (NCT03145129) | Papworth Hospital NHS Foundation Trust | 2017-03-24 |
| PAIR Study-PAP And IOP Relationship: Study 1 (NCT03127813) | Papworth Hospital NHS Foundation Trust | 2017-02-15 |
| Metabolomics in Surgical Ophthalmological Patients (NCT03098316) | Universitaire Ziekenhuizen KU Leuven | 2017-01-31 |
| Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost (NCT03331770) | Laboratorios Poen | 2017-01-06 |
| The Effects of Visior on Ocular Hemodynamics (NCT02959593) | Visior Technologies Ltd. | 2017-01-01 |
| Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma (NCT03483402) | University Hospital of Patras | 2016-12-01 |
| Advanced Glycation End Products as a Biomarker for Accelerated Ageing (NCT02863224) | University of Plymouth | 2016-08-01 |
| Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans (NCT02989207) | Guy's and St Thomas' NHS Foundation Trust | 2016-08-01 |
| Ahmed Glaucoma Valve Surgery With Mitomycin-C (NCT02805257) | University of California, San Francisco | 2016-06-01 |
| A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients (NCT03419975) | Taejoon Pharmaceutical Co., Ltd. | 2016-04-26 |
| Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) (NCT03257813) | Laboratorios Sophia S.A de C.V. | 2016-04-01 |
| InnFocus MicroShunt Versus Trabeculectomy Study (NCT01881425) | InnFocus Inc. | 2015-12-15 |
| A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- (NCT02623738) | Santen Pharmaceutical Co., Ltd. | 2015-12-06 |
| Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging (NCT01864317) | Medical University of Vienna | 2015-11-01 |
| A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma (NCT02792803) | Dr. David Yan | 2015-09-01 |
| Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension (NCT02801617) | Laboratorios Sophia S.A de C.V. | 2015-09-01 |
| An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert (NCT02537015) | ForSight Vision5, Inc. | 2015-08-10 |
| Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome (NCT04334564) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2015-04-28 |
| Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy (NCT02406833) | Isarna Therapeutics GmbH | 2015-04-01 |
| Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition (NCT02247284) | University of Zurich | 2015-03-01 |
| Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study (NCT02355990) | Sanoculis Ltd | 2015-02-01 |
| Dose-Ranging Study of the Bimatoprost Ocular Insert (NCT02358369) | ForSight Vision5, Inc. | 2015-01-19 |
| Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty (NCT02327312) | Glaukos Corporation | 2014-12-16 |
| Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (NCT02300818) | American Society Of Thermalism And Climatology Inc | 2014-11-01 |
| An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product (NCT02143843) | ForSight Vision5, Inc. | 2014-06-05 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration (NCT02144103) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2014-05-01 |
| Post Market Study of the InnFocus MicroShunt (NCT02177123) | InnFocus Inc. | 2014-04-04 |
| Imaging Lens Deposits in Exfoliation Syndrome (NCT02042703) | Duke University | 2014-02-01 |
| Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension (NCT02047630) | CHU de Quebec-Universite Laval | 2014-01-01 |
| Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma. (NCT02330978) | University of Sao Paulo | 2014-01-01 |
| Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension (NCT02059278) | Nephron Pharmaceuticals Corporation | 2014-01-01 |
| Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants (NCT02006693) | AqueSys, Inc. | 2013-12-05 |
| Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose (NCT02017327) | Laboratoires Thea | 2013-12-01 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension (NCT01915940) | ForSight Vision5, Inc. | 2013-10-23 |
| A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension (NCT01943721) | ForSight Vision5, Inc. | 2013-10-01 |
| An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More (NCT01979913) | Dr. Anton Hommer | 2013-10-01 |
| Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry (NCT01841437) | Glaukos Corporation | 2013-09-01 |
| The Effects of an Antioxidant Formulation on Ocular Blood Flow (NCT01930487) | ScienceBased Health | 2013-08-01 |
| Combined Viscocanalostomy, Phacoemulsification, OIogen Implant in Open Angle Glaucoma (NCT03782051) | Zagazig University | 2013-08-01 |
| Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma (NCT02805231) | Lv Yingjuan | 2013-07-01 |
| Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma (NCT03021629) | Lv Yingjuan | 2013-07-01 |
| Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma (NCT02539745) | Lv Yingjuan | 2013-07-01 |
| Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery (NCT01841450) | Glaukos Corporation | 2013-07-01 |
| Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost (NCT01896180) | Alleanza Pharmaceuticals, Inc. | 2013-07-01 |
| Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort (NCT01836042) | Glaukos Corporation | 2013-07-01 |
| Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients (NCT03104621) | Gangnam Severance Hospital | 2013-03-01 |
| Structure Function Correlation in Primary Open Angle Glaucoma (NCT02028572) | Vasan Eye Care Hospital | 2013-02-01 |
| Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma (NCT01795014) | Universitaire Ziekenhuizen KU Leuven | 2013-01-01 |
| IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty (NCT01767753) | Sensimed AG | 2012-11-01 |
| IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy (NCT01766947) | Sensimed AG | 2012-11-01 |